Your browser doesn't support javascript.
loading
Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study.
Erdem, Hakan; Baymakova, Magdalena; Alkan, Sevil; Letaief, Amel; Yahia, Wissal Ben; Dayyab, Farouq; Kolovani, Entela; Grgic, Svjetlana; Cosentino, Federica; Hasanoglu, Imran; Khedr, Reham; Marino, Andrea; Pekok, Abdullah Umut; Eser, Fatma; Arapovic, Jurica; Guner, Hatice Rahmet; Miftode, Ionela-Larisa; Poposki, Kostadin; Sanlidag, Gamze; Tahmaz, Alper; Sipahi, Oguz Resat; Miftode, Egidia Gabriela; Oncu, Serkan; Cagla-Sonmezer, Meliha; Addepalli, Syam Kumar; Darazam, Ilad Alavi; Kumari, Hema Prakash; Koc, Meliha Meriç; Kumar, Meela Ranjith; Sayana, Suresh Babu; Wegdan, Ahmed Ashraf; Amer, Fatma; Ceylan, Mehmet Resat; El-Kholy, Amani; Onder, Taylan; Tehrani, Hamed Azhdari; Hakamifard, Atousa; Kayaaslan, Bircan; Shehata, Ghaydaa; Caskurlu, Hulya; El-Sayed, Nagwa Mostafa; Mortazavi, Seyed Erfan; Pourali, Mohammad; Elbahr, Umran; Kulzhanova, Sholpan; Yetisyigit, Tarkan; Saad, Sahar Ahmed; Cag, Yasemin; Eser-Karlidag, Gulden; Pshenichnaya, Natalia.
Afiliación
  • Erdem H; Department of Infectious Diseases & Clinical Microbiology, Gulhane School of Medicine, Turkish Health Sciences University, Ankara, Turkey.
  • Baymakova M; Department of Infectious Diseases, Military Medical Academy, Sofia, Bulgaria.
  • Alkan S; Department of Infectious Diseases and Clinical Microbiology, Onsekiz Mart University School of Medicine, Canakkale, Turkey.
  • Letaief A; Department of Infectious Diseases, Farhat Hached University Hospital, Ibn El Jazzar Medical School, University of Sousse, Sousse, Tunisia.
  • Yahia WB; Department of Infectious Diseases, Farhat Hached University Hospital, Ibn El Jazzar Medical School, University of Sousse, Sousse, Tunisia.
  • Dayyab F; Department of Internal Medicine, King Hamad University Hospital, Al Sayh, Manama, Bahrain.
  • Kolovani E; Infectious Disease Clinic, University Hospital Center 'Mother Theresa', Tirana, Albania.
  • Grgic S; Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.
  • Cosentino F; Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, ARNAS Garibaldi Hospital, University of Catania, Catania, Italy.
  • Hasanoglu I; Department of Infectious Diseases & Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
  • Khedr R; Department of Pediatric Oncology, National Cancer Institute - Cairo University, Children Cancer Hospital Egypt, Cairo, Egypt.
  • Marino A; Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, ARNAS Garibaldi Hospital, University of Catania, Catania, Italy.
  • Pekok AU; VM Medical Park, Pendik Hospital, Istanbul, Turkey.
  • Eser F; Department of Infectious Diseases & Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
  • Arapovic J; Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.
  • Guner HR; Department of Infectious Diseases & Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
  • Miftode IL; St. Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.
  • Poposki K; Faculty of Medicine, University Clinic for Infectious Diseases and Febrile Conditions, Skopje, Republic of North Macedonia.
  • Sanlidag G; Department of Infectious Diseases & Clinical Microbiology, Ege School of Medicine, Izmir, Turkey.
  • Tahmaz A; Department of Infectious Diseases & Clinical Microbiology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Sipahi OR; Department of Infectious Diseases & Clinical Microbiology, Ege School of Medicine, Izmir, Turkey.
  • Miftode EG; St. Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.
  • Oncu S; Department of Infectious Diseases & Clinical Microbiology, School of Medicine, Adnan Menderes University, Aydin, Turkey.
  • Cagla-Sonmezer M; Department of Infectious Diseases & Clinical Microbiology, Hacettepe School of Medicine, Hacettepe University, Ankara, Turkey.
  • Addepalli SK; Department of Pharmacology, GITAM Institute of Medical Sciences and Research, Visakhapatnam, Andhra Pradesh, India.
  • Darazam IA; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kumari HP; Department of Microbiology, GITAM Institute of Medical Sciences and Research, Visakhapatnam, Andhra Pradesh, India.
  • Koc MM; Department of Infectious Diseases & Clinical Microbiology, School of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Kumar MR; Department of Pharmacology, Government Medical College &, Government General Hospital, Suryapet, Telangana, India.
  • Sayana SB; Department of Pharmacology, Government Medical College, Suryapet, Telangana, India.
  • Wegdan AA; Department of Medical Microbiology and Immunology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
  • Amer F; Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Ceylan MR; Department of Infectious Diseases & Clinical Microbiology, School of Medicine, Harran University, Sanliurfa, Turkey.
  • El-Kholy A; Department of Clinical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.
  • Onder T; Department of Infectious Diseases and Clinical Microbiology, Onsekiz Mart University School of Medicine, Canakkale, Turkey.
  • Tehrani HA; Department of Hematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hakamifard A; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kayaaslan B; Department of Infectious Diseases & Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
  • Shehata G; Department of Neurology, Assiut University, Assiut, Egypt.
  • Caskurlu H; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
  • El-Sayed NM; Medical Parasitology Department, Research Institute of Ophthalmology, Giza, Egypt.
  • Mortazavi SE; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Pourali M; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Elbahr U; Department of Infectious Diseases, Bahrain Oncology Center, King Hamad University Hospital, Busaiteen, Bahrain.
  • Kulzhanova S; Department of Infectious Diseases, Astana Medical University, Nur-Sultan, Kazakhstan.
  • Yetisyigit T; Department of Oncology, Bahrain Oncology Center, King Hamad University Hospital, Busaiteen, Bahrain.
  • Saad SA; Department of Rheumatology, King Hamad Univesity Hospital, Al Sayh, Bahrain.
  • Cag Y; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey. yasemncag@yahoo.com.
  • Eser-Karlidag G; Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Elazig Fethi Sekin City Hospital, Elazig, Turkey.
  • Pshenichnaya N; Central Research Institute of Epidemiology, Moscow, Russia.
Eur J Clin Microbiol Infect Dis ; 42(4): 387-398, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36790531
Fever of unknown origin (FUO) is a serious challenge for physicians. The aim of the present study was to consider epidemiology and dynamics of FUO in countries with different economic development. The data of FUO patients hospitalized/followed between 1st July 2016 and 1st July 2021 were collected retrospectively and submitted from referral centers in 21 countries through ID-IRI clinical research platform. The countries were categorized into developing (low-income (LI) and lower middle-income (LMI) economies) and developed countries (upper middle-income (UMI) and high-income (HI) economies). This research included 788 patients. FUO diagnoses were as follows: infections (51.6%; n = 407), neoplasms (11.4%, n = 90), collagen vascular disorders (9.3%, n = 73), undiagnosed (20.1%, n = 158), miscellaneous diseases (7.7%, n = 60). The most common infections were tuberculosis (n = 45, 5.7%), brucellosis (n = 39, 4.9%), rickettsiosis (n = 23, 2.9%), HIV infection (n = 20, 2.5%), and typhoid fever (n = 13, 1.6%). Cardiovascular infections (n = 56, 7.1%) were the most common infectious syndromes. Only collagen vascular disorders were reported significantly more from developed countries (RR = 2.00, 95% CI: 1.19-3.38). FUO had similar characteristics in LI/LMI and UMI/HI countries including the portion of undiagnosed cases (OR, 95% CI; 0.87 (0.65-1.15)), death attributed to FUO (RR = 0.87, 95% CI: 0.65-1.15, p-value = 0.3355), and the mean duration until diagnosis (p = 0.9663). Various aspects of FUO cannot be determined by the economic development solely. Other development indices can be considered in future analyses. Physicians in different countries should be equally prepared for FUO patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Enfermedades Transmisibles / Fiebre de Origen Desconocido Tipo de estudio: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Clin Microbiol Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Enfermedades Transmisibles / Fiebre de Origen Desconocido Tipo de estudio: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Clin Microbiol Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Turquía